Chengdu Kanghua Biological Products (300841) — Cash Flow-to-Debt Ratio
Chengdu Kanghua Biological Products (300841) has a Cash Flow-to-Debt Ratio of 0.22x as of September 2025, meaning its operating cash flow of CN¥92.89 Million could theoretically repay 0% of its total liabilities (CN¥430.82 Million) in one year. Check how aggressively does Chengdu Kanghua Biological Products reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chengdu Kanghua Biological Products Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Chengdu Kanghua Biological Products across 10 annual periods. Also explore Chengdu Kanghua Biological Products total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year debt coverage analysis for Chengdu Kanghua Biological Products. For market capitalisation and broader financial context, see Chengdu Kanghua Biological Products (300841) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | CN¥572.24 Million | CN¥580.07 Million | ▲ +19.5% |
| 2023 | 0.83x | CN¥573.98 Million | CN¥695.22 Million | ▲ +169.0% |
| 2022 | 0.31x | CN¥194.99 Million | CN¥635.40 Million | ▼ -18.1% |
| 2021 | 0.37x | CN¥130.33 Million | CN¥347.74 Million | ▼ -82.4% |
| 2020 | 2.13x | CN¥369.56 Million | CN¥173.24 Million | ▲ +33.7% |
| 2019 | 1.60x | CN¥182.73 Million | CN¥114.49 Million | ▲ +229.4% |
| 2018 | 0.48x | CN¥57.35 Million | CN¥118.37 Million | ▼ -53.5% |
| 2017 | 1.04x | CN¥89.96 Million | CN¥86.38 Million | ▲ +11610.7% |
| 2016 | 0.01x | CN¥2.64 Million | CN¥297.23 Million | ▼ -62.7% |
| 2015 | 0.02x | CN¥6.51 Million | CN¥272.61 Million | — |